ACTA1 and cancer: Considering that EMT is indispensable for fibrogenesis and tumorigenesis and biomarkers such as MMP and α-SMA are commonly employed to determine whether a drug is effective as a fibrosis or cancer treatment, we suggest that SUMOylation may be used in a novel fibrosis treatment through the inhibition of EMT.